Expert Analysis: Clinical Care Options Oncology - Ovarian Cancer

INDEPENDENT CONFERENCE COVERAGE 2010 American Society of Clinical Oncology Annual Meeting* *CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
	To: CCO member From: Thomas J. Herzog, MD Columbia University College of Physicians and Surgeons New York, New York Subject: CME/CE-Certified Expert Analysis From Chicago Click to Access: Ovarian Cancer
	While attending the clinical oncology meeting in Chicago, Illinois, I met with Bradley J. Monk, MD, to review the clinical implications of recent studies in ovarian cancer. Our discussion is available on the Clinical Care Options Web site as a CME/CE-certified Expert Analysis. Select topics include: Bevacizumab-Based First-line Regimen and Maintenance Therapy for Advanced Ovarian Cancer First-line Gemcitabine/Carboplatin vs Paclitaxel/Carboplatin, Followed by Paclitaxel Maintenance for Advanced Epithelial Ovarian Cancer Frontline PLD/Carboplatin vs Paclitaxel/Carboplatin for Advanced Ovarian Cancer Exploration of PARP Inhibitors in Ovarian Cancer With and Without BRCA Mutations New Antiangiogenesis Inhibitor for the Treatment of Recurrent Ovarian Cancer: AMG 386 Novel Monoclonal Antibody for the Treatment of Platinum-Sensitive Epithelial Ovarian Cancer: Farletuzumab Novel Vincristine-Based Agent for the Treatment of Platinum-Resistant Advanced Ovarian Cancer: EC125 Nab-Paclitaxel Plus Bevacizumab in Platinum-Resistant Primary Epithelial Ovarian Cancer or Primary Peritoneal Cancer Novel Irinotecan-Based Agent for the Treatment of Platinum-Resistant/Refractory Ovarian Cancer: NKTR-102 Platinum-Free Interval Extension With Trabectedin/PLD in Partially Platinum-Sensitive Recurrent Ovarian Cancer 2-Step Screening Strategy for Ovarian Cancer Using Annual CA-125 Measurement and Possible Transvaginal Ultrasound To review this CME/CE-certified Expert Analysis, click here. This Expert Analysis is located online at: http://clinicaloptions.com/Oncology/Conference%20Coverage/Clin%20Onc%20June%202010.aspx